TTS Pharma  

News

Personalized Medicine Advances, But Faces Challenges

Read more...

Bristol firm relocates with North West Fund cash

Read more...

Nicotine patch developers receive £550,000 investment

Read more...

Nicotine supplement company TTS Pharma to locate to North West following SPARK Impact-led investment

Read more...

The North West Fund for Biomedical Invests £550,000 in Personalised Smoking Cessation Product from TTS Pharma

Read more...

Statistics on NHS Stop Smoking Services: England, April 2012 to June 2012

Read more... 

Glowing DNA Invention Points Towards High Speed Disease Detection

Read more... 

Companion Diagnostics Take Off

Read more... 

Individual gene differences can be tested in zebrafish

Read more... 

Researchers identify unique immune gene signature across thousands of patients' solid tumors

Read more...

Website Builder